Condition

Disease Activity

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions2

Lead sponsors shown3

Clinical trials

3 shown

Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound FindingsNCT07374367 · 2026-05-01

NOT_YET_RECRUITING

The Effect of Cold Application in Patients With Rheumatoid ArthritisNCT07359326 · 2024-10-14

COMPLETED

14.0- 3.0- 3.0- η Protein With Rheumatoid ArthritisNCT05366608 · 2019-01-01

COMPLETED

Common interventions

Cold ApplicationBEHAVIORAL1 Serum level of 14.0- 3.0- 3.0- η protein and IL_.6DIAGNOSTIC_TEST1

Leading sponsors

Amera Imam Abdel - Ghany Ahmed 1 Mansoura University 1 Saglik Bilimleri Universitesi 1

Trial status mix

COMPLETED2

NOT_YET_RECRUITING1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.